Free Trial

TKG Advisors LLC Acquires Shares of 18,198 Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • TKG Advisors LLC established a new stake in Procter & Gamble (NYSE:PG), buying 18,198 shares in Q4 valued at about $2.61 million.
  • P&G beat Q3 EPS estimates ($1.59 vs. $1.53) but missed revenue ($21.24B vs. $21.52B) and set FY‑2026 EPS guidance of $6.83–$7.09, slightly below Street expectations, triggering analyst price‑target cuts and added near‑term downside risk.
  • Insiders sold a large amount of stock recently—252,715 shares worth roughly $40.97 million in the past three months, including CEO Ma. Fatima Francisco (8,000 shares) and Gary A. Coombe (36,093 shares)—with corporate insiders owning just 0.20% of the company.
  • Five stocks to consider instead of Procter & Gamble.

TKG Advisors LLC bought a new position in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 18,198 shares of the company's stock, valued at approximately $2,608,000.

Several other institutional investors and hedge funds have also made changes to their positions in PG. Halbert Hargrove Global Advisors LLC acquired a new position in Procter & Gamble in the third quarter worth $25,000. Maseco LLP bought a new position in shares of Procter & Gamble in the 4th quarter worth about $28,000. Saranac Partners Ltd acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at about $30,000. Corundum Trust Company INC bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $32,000. Finally, Caitlin John LLC bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $34,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In related news, CEO Ma. Fatima Francisco sold 8,000 shares of Procter & Gamble stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $158.00, for a total transaction of $1,264,000.00. Following the sale, the chief executive officer directly owned 6,571 shares in the company, valued at $1,038,218. The trade was a 54.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of the firm's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the transaction, the chief executive officer directly owned 34,994 shares in the company, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 252,715 shares of company stock valued at $40,966,904. 0.20% of the stock is owned by corporate insiders.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Q3 EPS topped estimates: P&G reported $1.59 EPS vs. $1.53 consensus and sales grew ~7%, showing resilient pricing/margin execution. Management reiterated its full‑year outlook. CNBC: Procter & Gamble earnings beat estimates as sales grow 7%
  • Positive Sentiment: Brand/product momentum: P&G earned top spot in Fortune’s “Most Innovative Companies” for household products and launched new Febreze TRASH, supporting long‑term organic growth and innovation premium. Fortune recognition Febreze TRASH launch
  • Neutral Sentiment: Market previews and commentary set modest expectations going into results; macro/consumer‑sentiment data remain the bigger cyclical risk for staples demand. Yahoo: Earnings, consumer sentiment preview
  • Neutral Sentiment: Corporate housekeeping: P&G management publicly refuted a mini‑tender offer (minor market noise, not operational). Yahoo: Mini‑tender discussion
  • Negative Sentiment: FY‑2026 guidance came in slightly below Street: EPS guided to $6.83–$7.09 (consensus ~6.95) and revenue guidance midpoint a touch under consensus — this cut in expected growth/beat cadence is the primary driver of the selloff. MarketBeat: Q3 results & guidance
  • Negative Sentiment: Quarterly revenue missed estimates ($21.23B vs. $21.52B), suggesting volume weakness offset by pricing — an earnings‑quality concern for some investors. CNBC: Revenue miss details
  • Negative Sentiment: Analysts trimmed targets/ratings after the print and guidance (Morgan Stanley, BNP Paribas Exane, BofA among firms lowering PTs), increasing near‑term downside risk from multiple sell‑side revisions. MarketScreener: BNP Paribas PT cut MarketScreener: Morgan Stanley PT cut InsiderMonkey: BofA resin‑cost note

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent research reports. BNP Paribas Exane cut their target price on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating on the stock in a report on Thursday. Royal Bank Of Canada dropped their price target on Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating on the stock in a research report on Thursday, April 9th. Erste Group Bank downgraded Procter & Gamble from a "buy" rating to a "hold" rating in a report on Tuesday, March 24th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a research report on Friday, April 17th. Finally, Morgan Stanley lowered their price objective on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a research note on Wednesday. Twelve analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $162.37.

Get Our Latest Report on Procter & Gamble

Procter & Gamble Price Performance

NYSE PG opened at $145.77 on Friday. The company has a 50-day moving average price of $150.56 and a two-hundred day moving average price of $148.72. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99. The stock has a market cap of $338.77 billion, a price-to-earnings ratio of 21.60, a price-to-earnings-growth ratio of 5.50 and a beta of 0.41. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.06. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company had revenue of $21.24 billion for the quarter, compared to analysts' expectations of $21.52 billion. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts forecast that Procter & Gamble Company will post 6.96 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be given a dividend of $1.0885 per share. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date is Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. Procter & Gamble's payout ratio is presently 62.67%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines